2006. Targeting tumor -related immunosuppression for cancer immunotherapy. Endocr Metab Immune Disord Drug V11.2 (1/9/20 ) Page 43 of 50 Targets 6, 233- 237. 18. Kim, R., Emi, M., Tanabe, K. & Arihiro, K.